Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption

Abstract

The HIV reservoir is responsible for persistent viral infection, and a small number of mosaic latent cellular reservoirs promote viral rebound upon antiretroviral therapy interruption, which is the major obstacle to a cure. However, markers that determine effective therapy and viral rebound post-treatment interruption remain unclear. Here we comprehensively and longitudinally tracked dynamic decay of cell-associated viral RNA/DNA in systemic and lymphoid tissues in SIV-infected rhesus macaques on prolonged combined antiretroviral therapy (cART) and evaluated predictors of viral rebound after treatment cessation. The results showed that suppressive ART substantially reduced plasma SIV RNA, cell-associated unspliced, and multiply spliced SIV RNA to undetectable levels, yet viral DNA remained detectable in systemic tissues and lymphoid compartments throughout cART. Intriguingly, a rapid increase of integrated proviral DNA in peripheral mononuclear cells was detected once treatment was withdrawn, accompanied by the emergence of detectable plasma viral load. Notably, the increase of peripheral proviral DNA post treatment interruption correlated with the emergence and degree of viral rebound. These findings suggest that measuring total viral DNA in SIV infection may be a relatively simple surrogate marker of reservoir size, and may predict viral rebound after treatment interruption, and inform treatment strategies. Importance Viral reservoirs are involved in persistent HIV infection, and a small number of mosaic latent cellular reservoirs promote viral rebound upon analytical treatment interruption, which are the major obstacle to a cure. However, early indicators that can predict resurgence of viremia after treatment interruption may aid treatment decisions in people living with HIV. Utilizing the rhesus macaque model, here we demonstrate increased proviral DNA in peripheral cells after treatment interruption, rather than levels of proviral DNA, was a useful marker to predict the emergence and degree of viral rebound after treatment interruption, providing a rapid approach for monitoring HIV rebound and informing decisions.

Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs

“…Another factor that could have influenced post-ART viral rebound is the size of the latent reservoir. Previous studies showed levels of proviral DNA in the GALT correlate with time to viral rebound [ 68 ], and increased proviral DNA in PBMC correlates with higher viral loads during ATI [ 69 ]. It is therefore possible that the controllers in this study had reduced proviral reservoirs that contributed to improved control of virus replication.…”

A Review on Zoonotic Pathogens Associated with Non-Human Primates: Understanding the Potential Threats to Humans

“…Simian T-cell leukemia virus type 1 (STLV-1) was first discovered in Japanese macaques in 1982 and classified as belonging to the Del-taretrovirus genus [ 56 ]. According to the provirus nucleic acid sequence and serological response, STLV was subdivided into STLV-1, STLV-2, STLV-3, and STLV-4.…”

Early Treatment Regimens Achieve Sustained Virologic Remission in Infant Macaques Infected with SIV at Birth

“…Quanti cation of plasma viral load and cell-associated SIV RNA and DNA Plasma viral load and cell-associated SIV RNA/DNA were measured by speci c primer sets and probes as previously described 95 . Brie y, the extracted RNA was reverse-transcribed into cDNA using a SuperScript III rst-strand synthesis system (Invitrogen) in a thermocycler at 25.0°C for 5 min and 50.0°C for 60 min, followed by an enzyme inactivation step at 70.0°C for 15 min.…”